1 Jun 2020 - The Edge Markets
SINGAPORE (June 1): Singapore eDevelopment (SeD) announced on Monday that its wholly-owned subsidiary Impact Biomedical’s suite of antiviral and medical technologies, which is co-owned by its scientific research partner, Global Research and Discovery Group Sciences (GRDG Sciences), is valued at $1.97 ...
sgx:40v